Want to see HK:6078 full AI Analyst Report?
6078 Stock Chart & Stats
HK$10.13
HK$0.07(0.70%)
At close: 4:00 PM EDT
HK$10.13
HK$0.07(0.70%)
Day’s Range― - ―
52-Week RangeHK$8.10 - HK$15.65
Previous CloseN/A
Volume725.80K
Average Volume (3M)7.15M
Market Cap
HK$6.12B
Enterprise ValueHK$9.60K
Total Cash (Recent Filing)HK$741.02M
Total Debt (Recent Filing)HK$2.45B
Price to Earnings (P/E)124.1
Beta1.44
Next Earnings
Mar 31, 2027EPS Estimate
0.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding618,499,000
10 Day Avg. Volume3,556,037
30 Day Avg. Volume7,151,771
Financial Highlights & Ratios
PEG Ratio-0.58
Price to Book (P/B)1.02
Price to Sales (P/S)1.72
P/FCF Ratio14.79
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$13.50Price Target Upside33.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)0.86
Revenue Forecast (FY)HK$4.26B
Bulls Say, Bears Say
Bulls Say
Healthcare Demand And Complex-procedure GrowthRising patient volumes and faster growth in complex procedures support utilization, clinical mix and hospital relevance. Continued expansion in cancer care, critical treatment and advanced surgery could strengthen durable demand and competitive positioning.
Manageable Leverage And Expanding Capital BaseModerate leverage and a growing equity base provide financial flexibility for hospital investment and measured expansion. Lower balance-sheet strain also reduces refinancing risk and gives management more capacity to absorb earnings volatility.
Improving Cash Generation And Capital DisciplinePositive operating cash flow and a free-cash-flow recovery improve the funding base for hospital operations and growth. Lower capital spending and interest-bearing liabilities may further support reinvestment and shareholder returns over the next several quarters.
Bears Say
Latest Revenue ContractionThe latest contraction interrupts the company’s longer-term expansion record and may indicate weaker utilization, pricing, or portfolio conditions. Sustained revenue pressure would reduce operating leverage and make margin recovery more difficult.
Sharp Profitability DeteriorationThe large margin decline shows that revenue growth has not translated consistently into earnings. Unless costs, pricing pressure or other profitability headwinds moderate, weaker returns could constrain internal funding and lower the resilience of the hospital model.
Volatile And Incomplete Cash ConversionAlthough cash generation improved, inconsistent conversion from accounting earnings and prior negative free cash flow indicate working-capital or reinvestment volatility. This can limit dependable funding for expansion and make shareholder-return commitments more conditional.
Hygeia Healthcare Holdings Co., Ltd. News
6078 FAQ
What was Hygeia Healthcare Holdings Co., Ltd.’s price range in the past 12 months?
Hygeia Healthcare Holdings Co., Ltd. lowest stock price was HK$8.10 and its highest was HK$15.65 in the past 12 months.
What is Hygeia Healthcare Holdings Co., Ltd.’s market cap?
Hygeia Healthcare Holdings Co., Ltd.’s market cap is HK$6.12B.
When is Hygeia Healthcare Holdings Co., Ltd.’s upcoming earnings report date?
Hygeia Healthcare Holdings Co., Ltd.’s upcoming earnings report date is Mar 31, 2027 which is in 215 days.
How were Hygeia Healthcare Holdings Co., Ltd.’s earnings last quarter?
Hygeia Healthcare Holdings Co., Ltd. released its earnings results on Aug 27, 2026. The company reported HK$0.49 earnings per share for the quarter, beating the consensus estimate of HK$0.35 by HK$0.14.
Is Hygeia Healthcare Holdings Co., Ltd. overvalued?
According to Wall Street analysts Hygeia Healthcare Holdings Co., Ltd.’s price is currently Undervalued.
Does Hygeia Healthcare Holdings Co., Ltd. pay dividends?
Hygeia Healthcare Holdings Co., Ltd. pays a Notavailable dividend of HK$0.164 which represents an annual dividend yield of N/A. See more information on Hygeia Healthcare Holdings Co., Ltd. dividends here
What is Hygeia Healthcare Holdings Co., Ltd.’s EPS estimate?
Hygeia Healthcare Holdings Co., Ltd.’s EPS estimate is 0.4.
How many shares outstanding does Hygeia Healthcare Holdings Co., Ltd. have?
Hygeia Healthcare Holdings Co., Ltd. has 618,499,000 shares outstanding.
What happened to Hygeia Healthcare Holdings Co., Ltd.’s price movement after its last earnings report?
Hygeia Healthcare Holdings Co., Ltd. reported an EPS of HK$0.49 in its last earnings report, beating expectations of HK$0.35. Following the earnings report the stock price went down -0.348%.
Which hedge fund is a major shareholder of Hygeia Healthcare Holdings Co., Ltd.?
Currently, no hedge funds are holding shares in HK:6078
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hygeia Healthcare Holdings Co., Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.92%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2.60%
Trailing 12-Months
Company Description
Hygeia Healthcare Holdings Co., Ltd.
Hygeia Healthcare Holdings Co., Limited (6078.HK) is a prominent oncology healthcare provider primarily operating across the People's Republic of China. The company owns and manages a network of private, for-profit hospitals specializing in comprehensive cancer care. These facilities offer a broad spectrum of services, including diagnostic procedures such as tumor screening and genetic analysis, advanced therapeutic interventions like radiotherapy, surgery, chemotherapy, immunotherapy, and targeted treatments, alongside crucial supportive care including oncology rehabilitation, nutritional guidance, and hospice services. Beyond direct patient care, Hygeia also provides consulting expertise for radiotherapy centers and licenses its specialized SRT (Stereotactic Radiotherapy) equipment, offering ongoing maintenance and technical support for these systems. The company's operations extend to providing hospital and corporate management services, as well as supply chain solutions. By the end of 2021, Hygeia Healthcare had established a significant presence, operating or managing 12 oncology-focused hospitals spread across 9 cities in 7 provinces throughout mainland China. Established in 2009, the company maintains its headquarters in Shanghai, PRC.
6078 Stock 12 Month Forecast
Average Price Target
HK$13.50
▲(33.27% Upside)
Technical Analysis
Aidigong Maternal & Child Health
―
Jinxin Fertility Group Ltd.
―
C-MER Eye Care Holdings Limited
―
Town Health International Medical Group Ltd.
―
Arrail Group Ltd.
―








